EN001 ( DrugBank: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
10	シャルコー・マリー・トゥース病	1
113	筋ジストロフィー	1

10. シャルコー・マリー・トゥース病

臨床試験数 : 41 / 薬物数 : 46 - (DrugBank : 9) / 標的遺伝子数 : 11 - 標的パスウェイ数 : 15

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05333406 (ClinicalTrials.gov)	February 22, 2022	6/1/2022	Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A	Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001in Pati ...	Charcot-Marie-Tooth Disease, Type IA	Drug: EN001	ENCell	NULL	Completed	19 Years	75 Years	All	9	Phase 1	Korea, Republic of

臨床試験数 : 646 / 薬物数 : 471 - (DrugBank : 105) / 標的遺伝子数 : 59 - 標的パスウェイ数 : 170

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05338099 (ClinicalTrials.gov)	January 18, 2022	6/1/2022	Determine the Safety and Dose of EN001 in Patients With Duchenne Muscular Dystrophy(DMD)	Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001in Pati ...	Duchenne Muscular Dystrophy	Drug: EN001	ENCell	NULL	Completed	2 Years	18 Years	Male	7	Phase 1	Korea, Republic of